CN1415370A - Medicament for curing stomach-ache - Google Patents
Medicament for curing stomach-ache Download PDFInfo
- Publication number
- CN1415370A CN1415370A CN 02146257 CN02146257A CN1415370A CN 1415370 A CN1415370 A CN 1415370A CN 02146257 CN02146257 CN 02146257 CN 02146257 A CN02146257 A CN 02146257A CN 1415370 A CN1415370 A CN 1415370A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- rhizoma
- medicine
- powder
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating stomach-ache and gastric ulcer is prepared from 10 Chinese-medicinal materials including bupleurum root, tangerine peel, cyperus tuber, bitter orange, etc.
Description
Technical field
The present invention relates to a kind of medicine, particularly relate to a kind of medicine for the treatment of stomachache.
Background technology
Stomachache is common in diseases such as chronic gastritis, duodenitis, peptic ulcer, gastritis, and these diseases are all relevant with helicobacter pylori, and Chinese medicine thinks that these diseases are by gastric qi pent-up, caused by energy stagnation and blood stasis.
Technology contents
The object of the invention is to provide a kind of medicine for the treatment of stomachache and preparation method thereof.
The present invention seeks to be achieved through the following technical solutions:
Radix Bupleuri 100-150 weight portion Pericarpium Citri Reticulatae 100-150 weight portion
Rhizoma Cyperi 100-200 weight portion Fructus Aurantii 100-150 weight portion
Rhizoma Corydalis 90-120 weight portion Radix Paeoniae Rubra 60-100 weight portion
Fructus Evodiae 60-100 weight portion Rhizoma Coptidis 60-100 weight portion
Pseudobulbus Bletillae (Rhizoma Bletillae) 60-100 weight portion Radix Glycyrrhizae Preparata 60-100 weight portion
It is standby that above medical material Rhizoma Bletillae powder is broken into 100 order fine powders, Pericarpium Citri Reticulatae half, Rhizoma Cyperi is ground into coarse powder, doubly measures 70-90% ethanol with 6-10, dipping, slowly percolation is collected percolate, reclaims ethanol, is concentrated into the thick paste shape; Medicinal residues add 7 flavor medical materials such as Radix Bupleuri, decoct with water 2-4 time, decoct 1-2 hour at every turn, add 8-12 times of water gaging, merge decoction liquor, filter, filtrate is concentrated into 80 ℃ of following proportions 1.08, put coldly, add ethanol, make to contain the alcohol amount and reach 50-65%, leave standstill, filter, reclaim ethanol, merge above-mentioned thick paste, drying is made dried cream, crushing screening, add Rhizoma Bletillae powder and second half Pericarpium Citri Reticulatae powder, make clinical acceptable forms, as tablet, pill, oral liquid, capsule, granule etc.
Experimental example:
Capsule (the Asia stomach open capsule) main pharmacodynamics of the present invention's preparation
1, the logical antiulcer action of Asia stomach to experimental gastric ulcer
1.1 rats acetic acid calcination gastric ulcer model
Wistar rat fasting 24 hours is freely drunk water.Etherization, the sterile working in the positive split shed of xiphoid-process, gently pulls out stomach.Cut an osculum at stomach, on glandular stomach portion antetheca hole body boundary serosal surface, sticking the area that is soaked with glacial acetic acid is 5 * 5mm
2Circular filter paper.Take off filter paper after 90 seconds, sew up stomach, stomach is sent back to gently, sew up abdominal muscle and skin.Postoperative is normally raised, animal random packet and give relative medicine after 2 days, and gastric infusion is 9 continuously.Behind last administration 2h, put to death, cut open the belly, ligation pylorus and cardia.Get stomach, inject 1% formalin 5ml, stomach is immersed in 1% formalin fixedly 10min from glandular stomach portion.Cut off along greater gastric curvature then, normal saline washes away content, and anatomic microscope is observed the gastric mucosa injury situation and calculated the ulcer area, compares between each group.
The result shows that with the matched group ratio, the gastric ulcer area of the logical large and small dosage group of Asia stomach has reduced 62.9% (P＜0.01) and 41.3% (P＜0.05) respectively.The energy-stagnation stomachache group also has the significance inhibitory action to the formation of gastric ulcer, and the ulcer area has reduced by 45.5% (P＜0.05).
1.2 rat pylorus ligation gastric ulcer model
Wistar rat grouping administration is seen before and is stated.Behind the continuous irrigation stomach 6 days, fasting 72h (can't help water, not banning drugs) under etherization afterwards, opens the abdominal cavity, the ligation pylorus, and water is prohibited in fasting, and disconnected neck is put to death rat behind the 18h.Stomach is got in dissection, and formaldehyde fixed is the same, and 10min tailing edge greater gastric curvature is cut off stomach, measures and calculating ulcer area, carries out statistical analysis with its summation as ulcer index.Experimental result shows that logical heavy dose of group of Asia stomach and small dose group make the gastric ulcer damage index reduce 60.6% (P＜0.05) and 50.8% (P＜0.05) respectively.
1.3 rat indometacin gastric ulcer model
Wistar rat grouping administration is the same.Behind the continuous irrigation stomach 7 days, fasting 36h (can't help water, not banning drugs), 1h after the last administration, lumbar injection 0.5% indometacin 1ml/100g.Behind the 7h animal is all taken off neck and put to death, cut open the belly immediately, behind stomach cardia and pylorus ligation, formaldehyde fixed.10min tailing edge greater gastric curvature is cut off stomach, and it is damaged to examine stomach mucosa, and anatomic microscope is measured the sticking unconcerned damaged length (mm) of stomach down, carries out statistical analysis with its summation as ulcer index.Experimental result shows that stomach logical heavy dose of group in Asia makes ulcer index reduce by 59.3% (P＜0.05), and the energy-stagnation stomachache group makes ulcer index reduce by 71.1% (P＜0.01).
2, mouse small intestine ahead running experiment
Kunming mouse grouping administration is seen before and is stated.Gastric infusion is 5 days continuously, behind the last medicine 15 minutes, irritate stomach and give carbon powder arabic gum suspension 0.1ml/10g, put to death animal after 15 minutes, measurement from the stomach pylorus to ileocecus small intestinal total length and charcoal end the distance of dividing a word with a hyphen at the end of a line in small intestinal, calculate the intestinal propulsion percentage rate as follows.
The result shows that the mouse small intestine propelling rate of the logical large and small dosage group of Asia stomach has increased by 38.9% (P＜0.01) and 18.5% (P＜0.05) than normal control group respectively.
3. the logical influence of Asia stomach to helicobacter pylori
The helicobacter pylori type strain is inoculated 10% calf serum brucella broth, under little oxygen condition, cultivates 3 days for 37 ℃, is diluted to 3 * 10 with physiological saline solution before the test
6CFU/ml concentration bacteria suspension.After medicine ground, being diluted to concentration respectively with normal saline was 50%, 25%, 12.5%, 6.25%, 3.125% medicinal liquid (w/v).Be mixed and made into flat board with culture medium and each medicinal liquid by 9: 1, each dull and stereotyped medicine depth bounds is 3.125～50mg/ml.Get 0.1ml 3 * 10
6The CFU/ml bacteria suspension is inoculated in beautiful fat surface, makes its even coating, and little oxygen condition is cultivated 72h, observes minimal inhibitory concentration (MIC).The result shows that Asia stomach open capsule medicated powder has the obvious suppression effect to the type strain helicobacter pylori.Asia stomach open capsule medicated powder concentration suppresses helicobacter pylori fully when 12.5mg/ml is above.
4. the Asia stomach is logical to gastric juice, pepsic influence
Wistar rat grouping administration is seen before and is stated, gastric infusion after 5 days continuously, fasting 24h (can't help water, not banning drugs).1h after the last administration uses etherization, opens one in xiphoid-process lower edge hunter's line and is about the 2.5cm otch, carefully mentions stomach, pricks with toe-in at pylorus and duodenum joint portion.Postoperative is sewed up and is sent back in the cage, and water is prohibited in fasting, puts to death rat behind the 5h.Collect gastric juice, the centrifugal 10min of 3000 commentaries on classics/min, record supernatant liquid measure is the gastric juice amount, and measures total acidity, total acid output and pepsin activity.
Gastric acidity determination: get gastric juice 2ml at previous night and put in the small beaker, add start going to a nursery Fo Shi liquid and 2 of phenolphthalein indicators and (be cherry red when containing free acid, be not yellow when having the acid of trip glass), with slowly titration of NaOH 0.02mol/L (using burette), constantly shake simultaneously, it is yellow to drip the extremely red appearance that disappears, and continuation till blush was not moved back in 2 seconds, is the total acidity titration end-point with the titration of NaOH solution.The milliliter number of record NaOH that titration consumes.
Milliliter number * 10 of total gastric acidity NaOH that (mmol/L)=titration consumed.
The gastric juice amount of total acid output (μ mol/h)=total gastric acid * per hour.
Pepsin is measured: adopt the Mett capillary tube method.It is long that the glass capillary that internal diameter 1～2mm is well-balanced is cut into 10cm, cleans and dry.Get Ovum Gallus domesticus album and fully beat even back and use filtered through gauze, utilize siphonage that the capillary pipe of coming off duty is filled Ovum Gallus domesticus album (in noting managing bubble must not be arranged).Be placed on then in 85 ℃ of hot water and make protein coagulation, standby in the storage refrigerator.Get gastric juice 1mol and put into the 50ml beaker, add the 0.05mol/L hydrochloric acid solution, put 2 of protein pipe into.Filled in bottleneck, temperature is incubated 24h in 37 ℃ of calorstats.Take out protein pipe, measure the length (mm) of protein pipe two ends transparent part, ask its meansigma methods with the value of four ends.Every ml pepsin activity unit=meansigma methods
2* 16.
The result shows, the logical effect with minimizing rat stomach liquid measure and total acid output of Asia stomach.
5. experiment conclusion
Damage has significant protective effect to the logical Chinese medicine powder gastric infusion of Asia stomach to the kinds of experiments gastric ulcer, can reduce rat stomach liquid measure and total acid output.The mouse small intestine ahead running is had potentiation, lumbar injection acetic acid induced mice pain reaction is had inhibitory action.The Asia stomach is logical to have significant inhibitory effect to the helicobacter pylori type strain.
Embodiment:
Radix Bupleuri 137g Pericarpium Citri Reticulatae 137g Rhizoma Cyperi 164g Fructus Aurantii 137g
Rhizoma Corydalis 110g Radix Paeoniae Rubra 82g Fructus Evodiae 82g Rhizoma Coptidis 82g
Pseudobulbus Bletillae (Rhizoma Bletillae) 82g Radix Glycyrrhizae Preparata 82g
It is standby that above medical material Rhizoma Bletillae powder is broken into 100 order fine powders, Pericarpium Citri Reticulatae half, Rhizoma Cyperi is ground into coarse powder, according to percolation under the fluid extract item,, flood after 24 hours with 8 times of amount 80% alcohol, percolation slowly, the collection percolate, recovery ethanol is concentrated into the thick paste shape; Medicinal residues add 7 flavor medical materials such as Radix Bupleuri, decoct with water secondary, and 12 times of water gagings decocted 2 hours for the first time,, 10 times of water gagings decocted 1 hour for the second time, and decoction liquor, filter, filtrate is concentrated into proportion 1.08 (80 ℃), puts coldly, adds ethanol, make and contain alcohol amount and reach 60%, left standstill 24 hours, and filtered, reclaim ethanol, merge above-mentioned thick paste, drying is made dried cream, and crushing screening adds Rhizoma Bletillae powder and second half Pericarpium Citri Reticulatae powder (processing of 40 mesh sieves) and adjuvant mix homogeneously, adorn capsule No. one, make 1000, the heavily about 0.3g of capsule, promptly.
Claims (9)
1, a kind of pharmaceutical composition for the treatment of stomachache is characterized in that this medicine made by following crude drug:
Radix Bupleuri 100-150 weight portion Pericarpium Citri Reticulatae 100-150 weight portion
Rhizoma Cyperi 100-200 weight portion Fructus Aurantii 100-150 weight portion
Rhizoma Corydalis 90-120 weight portion Radix Paeoniae Rubra 60-100 weight portion
Fructus Evodiae 60-100 weight portion Rhizoma Coptidis 60-100 weight portion
Pseudobulbus Bletillae (Rhizoma Bletillae) 60-100 weight portion Radix Glycyrrhizae Preparata 60-100 weight portion
2, pharmaceutical composition as claimed in claim 1 is characterized in that this medicine made by following crude drug:
Radix Bupleuri 137 weight portion Pericarpium Citri Reticulataes 137 weight portions
Rhizoma Cyperi 164 weight portion Fructus Aurantiis 137 weight portions
Rhizoma Corydalis 110 weight portion Radix Paeoniae Rubra 82 weight portions
Fructus Evodiae 82 weight portion Rhizoma Coptidis 82 weight portions
Pseudobulbus Bletillae (Rhizoma Bletillae) 82 weight portion Radix Glycyrrhizae Preparatas 82 weight portions
3,, it is characterized in that this method is as the described preparation of drug combination method of claim 1-2:
It is standby that the medical material Rhizoma Bletillae powder is broken into 100 order fine powders, Pericarpium Citri Reticulatae half, Rhizoma Cyperi is ground into coarse powder, doubly measures 70-90% ethanol with 6-10, dipping, slowly percolation is collected percolate, reclaims ethanol, is concentrated into the thick paste shape; Medicinal residues add 7 flavor medical materials such as Radix Bupleuri, decoct with water 2-4 time, decoct 1-2 hour at every turn, add 8-12 times of water gaging, merge decoction liquor, filter, filtrate is concentrated into 80 ℃ of following proportions 1.08, puts coldly, adds ethanol, make to contain alcohol amount and reach 50-65%, leave standstill, filter, reclaim ethanol, merge above-mentioned thick paste, drying is made dried cream, crushing screening adds Rhizoma Bletillae powder and second half Pericarpium Citri Reticulatae powder, makes clinical acceptable forms.
4, preparation method as claimed in claim 3 is characterized in that this method is:
It is standby that above medical material Rhizoma Bletillae powder is broken into 100 order fine powders, Pericarpium Citri Reticulatae half, Rhizoma Cyperi is ground into coarse powder, with 8 times of amount 80% ethanol, flood after 24 hours, slowly percolation is collected percolate, recovery ethanol is concentrated into the thick paste shape; Medicinal residues add 7 flavor medical materials such as Radix Bupleuri, decoct with water secondary, decoct 2 hours for the first time, add 12 times of water gagings, decocted 1 hour for the second time, add 10 times of water gagings, merge decoction liquor, filter, filtrate is concentrated into proportion 1.08, puts coldly, adds ethanol, makes to contain the alcohol amount and reach 60%, left standstill 24 hours, and filtered, reclaim ethanol, merge above-mentioned thick paste, drying is made dried cream, crushing screening, add Rhizoma Bletillae powder and second half Pericarpium Citri Reticulatae powder and adjuvant mix homogeneously, encapsulated, promptly.
5, as the application of the described pharmaceutical composition of claim 1-2 in the medicine of preparation treatment gastric ulcer.
6, as the application of the described pharmaceutical composition of claim 1-2 in the medicine of preparation minimizing gastric juice amount and total acid output.
7, has application in the medicine that strengthens the intestinal propulsion motion as the described pharmaceutical composition of claim 1-2 in preparation.
8, has inhibition because of the application in the medicine of the pain caused reaction of acid as the described pharmaceutical composition of claim 1-2 in preparation.
9, has application in the medicine that suppresses helicobacter pylori as the described pharmaceutical composition of claim 1-2 in preparation.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02146257 CN1415370A (en) | 2002-10-17 | 2002-10-17 | Medicament for curing stomach-ache |
| HK03104238A HK1051769A2 (en) | 2002-10-17 | 2003-06-13 | A chinese patent drug for treating stomachache |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02146257 CN1415370A (en) | 2002-10-17 | 2002-10-17 | Medicament for curing stomach-ache |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1415370A true CN1415370A (en) | 2003-05-07 |
Family
ID=4751038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02146257 Pending CN1415370A (en) | 2002-10-17 | 2002-10-17 | Medicament for curing stomach-ache |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN1415370A (en) |
| HK (1) | HK1051769A2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1307972C (en) * | 2005-11-02 | 2007-04-04 | 那丽茹 | Stomachache treating Chinese medicine |
| CN100374145C (en) * | 2006-04-28 | 2008-03-12 | 四川宝光药业股份有限公司 | A medicine for treating gastric disease and preparation method thereof |
| CN100391527C (en) * | 2005-05-24 | 2008-06-04 | 马希文 | Medicine for treating gastrodynia disease |
| CN103239538A (en) * | 2013-01-15 | 2013-08-14 | 湖南新汇制药股份有限公司 | Helicobacter pylori-resisting pharmaceutical composition for stomach illness |
| CN107997166A (en) * | 2016-11-01 | 2018-05-08 | 北京振东光明药物研究院有限公司 | A kind of health products and preparation method for improving sleep, relieving fatigue strengthen immunity |
-
2002
- 2002-10-17 CN CN 02146257 patent/CN1415370A/en active Pending
-
2003
- 2003-06-13 HK HK03104238A patent/HK1051769A2/en not_active IP Right Cessation
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100391527C (en) * | 2005-05-24 | 2008-06-04 | 马希文 | Medicine for treating gastrodynia disease |
| CN1307972C (en) * | 2005-11-02 | 2007-04-04 | 那丽茹 | Stomachache treating Chinese medicine |
| CN100374145C (en) * | 2006-04-28 | 2008-03-12 | 四川宝光药业股份有限公司 | A medicine for treating gastric disease and preparation method thereof |
| CN103239538A (en) * | 2013-01-15 | 2013-08-14 | 湖南新汇制药股份有限公司 | Helicobacter pylori-resisting pharmaceutical composition for stomach illness |
| CN103239538B (en) * | 2013-01-15 | 2015-07-29 | 湖南新汇制药股份有限公司 | A kind of gastropathy drug composition of anti-helicobacter pylori |
| CN107997166A (en) * | 2016-11-01 | 2018-05-08 | 北京振东光明药物研究院有限公司 | A kind of health products and preparation method for improving sleep, relieving fatigue strengthen immunity |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1051769A2 (en) | 2003-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1657060A (en) | Shenkang freeze-dried powder injection for injection and its preparation technology | |
| CN106974952A (en) | Application of the fresh ginseng activity extract in treatment oral cavity and digestive tract ulcer medicine is prepared | |
| CN102293936B (en) | Medicinal composition or health food composition for protecting gastric mucosa, and preparation method thereof | |
| CN101780227B (en) | Traditional Chinese medicine composition for treating acute stroke and preparation method thereof | |
| CN1415370A (en) | Medicament for curing stomach-ache | |
| CN100415209C (en) | Cough stopping preparation and process for preparing the same | |
| CN101744986B (en) | Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof | |
| CN1654060A (en) | 'Kidney-Benefiting' glucose injection and its preparing process | |
| CN107266599B (en) | Flammulina velutipes, extracting method and its application in terms of functional consitipation drug is treated in preparation | |
| CN100509010C (en) | Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof | |
| CN105395600A (en) | Application of cyclocarya paliurus extract in preparing medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101249223A (en) | Chinese native medicine and western medicine compound preparations for curing coryza cold | |
| CN101559166B (en) | Ophiopogon japonicus extract, preparation method and hypoglycemic application thereof | |
| CN101559081B (en) | Application of river clam extract in preparation of medicament for curing and preventing diabetes mellitus | |
| CN101744993B (en) | Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof | |
| CN100540017C (en) | A kind of Chinese medicine preparation for the treatment of angina pectoris and preparation method thereof | |
| CN101745008B (en) | Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN101744997B (en) | Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN101744996B (en) | Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN100434092C (en) | Prescription containing sweet clover component and its formulation | |
| CN110314219A (en) | A kind of spray for diabetic complication | |
| CN101744987B (en) | Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN101744999B (en) | Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof | |
| CN108143952A (en) | A kind of preparation method of plant hypoglycemic agent | |
| CN101744990B (en) | Method for individually extracting ginseng, radix ophiopogonis and schisandra chinensis and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |